Tamoxifen for Breast Cancer: 162 Real Stories

162 stories match breast cancer and tamoxifen. 150 of them mention surgery.

Cancer Stories

Graciela, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Graciela's Patient Story

Patient Info: Graciela | Stage II

Graciela remained in treatment with tamoxifen after lumpectomy for stage 2 breast cancer; radiation therapy had also been recommended.

Our Cancer Stories
OutcomeCare Ongoing
Jenna, who was diagnosed with Breast CancerBreast Cancer

HR-Positive Breast Cancer: Jenna's Patient Story

Patient Info: Jenna, Female, Under 40

Biomarkers: ER-positive

Jenna completed 10 rounds of chemotherapy and double mastectomy for ER-positive breast cancer with lymph-node involvement. She was recovering, planning reconstruction, and preparing for long-term tamoxifen.

breastcancer.org
OutcomeCare Ongoing
A patient, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Goodie16's Story: Grand Mal Seizure Uncovers Metastatic Breast Cancer in the Brain

Patient Info: Goodie16 | Stage IV

Biomarkers: Oncotype DX recurrence score 12; ER, PR, and HER2 results not reported

Metastatic Site: brain

After removal and Gamma Knife treatment of a solitary brain metastasis, Goodie16 had a clear brain MRI in March 2016 and a PET scan showing no evidence of disease in September 2015 while continuing hormonal treatment.

breastcancer.org
OutcomeCancer-Free / NED
Kattysmith, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Kattysmith's Patient Story

Patient Info: Kattysmith, Female, 60s | Stage IV

Metastatic Site: lymphatic system; skin/soft-tissue nodules; possible…

After AC chemotherapy, the metastatic nodules shrank markedly. Kattysmith was stable on palbociclib and letrozole with declining tumor markers, while clearly stating that she was not NED.

breastcancer.org
OutcomeResponding Well
Ana, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Ana's Patient Story

Patient Info: Ana, Female, 40s

Biomarkers: Hormone-dependent tumor

Ana completed surgery, 6 months of chemotherapy, and 16 radiation sessions for hormone-dependent breast cancer and continued Tamoxifen plus quarterly Zoladex as recurrence-prevention therapy.

MatchTrial Historias Reales
OutcomeCare Ongoing
Sandra, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Sandra's Survivor Story

Patient Info: Sandra Christianson, Female, 40s

Sandra completed treatment for a first invasive breast cancer in 2012 and later completed surgery, chemotherapy, and radiation for a second invasive breast cancer in the opposite breast, choosing not to take anastrozole afterward.

BreastCancer.org (ES)
OutcomeSurvivorship / Completed Treatment
Gerda, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Gerda's Patient Story

Patient Info: Gerda Martin, Female, 70+

Gerda had completed right mastectomy, chemotherapy, radiation, and rehabilitation, declined reconstruction, and continued tamoxifen, bisphosphonates, lymph drainage, and follow-up care while adapting to body changes.

Krankheitserfahrungen.de
OutcomeCare Ongoing
Silke, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Silke's Survivor Story

Patient Info: Silke Winter, Female, 50s

Silke completed breast-conserving surgery and radiation, received anti-hormone therapy, returned to work, used rehabilitation and psycho-oncology, and rebuilt life priorities after false alarms during follow-up.

Krankheitserfahrungen.de
OutcomeSurvivorship / Completed Treatment
Tova, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Tova's Patient Story

Patient Info: Tova Goldblum, Female, 60s | Stage IV

Metastatic Site: Metastatic sites not specified

Tova had breast cancer diagnosed in 1992, later lived for many years with metastases, continued long-term Tamoxifen and regular 6-month checks, and used faith, self-help, writing, and long-term planning to live actively with cancer.

Krankheitserfahrungen.de
OutcomeLiving With Cancer
Nurguel, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Nurguel's Patient Story

Patient Info: Nurguel Dogan, Female, 40s

Nurguel completed neoadjuvant chemotherapy, tumor surgery with mastectomy and immediate silicone implant, and continued hormone therapy, while relying strongly on her husband, siblings, faith, and positive self-presentation.

Krankheitserfahrungen.de
OutcomeCare Ongoing
Nicole, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Nicole's Survivor Story

Patient Info: Nicole Bissinger, Female, 40s

Nicole completed surgery, chemotherapy, anti-hormone injections, and DIEP-flap reconstruction for Paget carcinoma, later described major side effects and body-image recovery, and used writing to process the illness.

Krankheitserfahrungen.de
OutcomeSurvivorship / Completed Treatment
Waltraud, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Waltraud's Survivor Story

Patient Info: Waltraud Amann, Female, 60s

Waltraud lived more than 18 years after her first breast cancer, experienced a right-axillary recurrence, returned to work through a gradual model, and managed long-term lymphoedema and menopausal symptoms during survivorship.

Krankheitserfahrungen.de
OutcomeSurvivorship / Completed Treatment
Katie, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Stage IV Invasive Lobular Carcinoma: Katie's Patient Story

Patient Info: Katie, Female, 50s | Stage IV

Metastatic Site: Stomach | Pelvis | Spine

Katie was living with metastatic ILC involving the stomach wall, pelvis, and spine while taking ribociclib (Kisqali) with letrozole, with improved stomach findings and stable spine metastases after 6 rounds.

Lobular Breast Cancer Alliance
OutcomeResponding Well
Alma, who was diagnosed with Stage II Invasive Lobular CarcinomaBreast Cancer

Stage II Invasive Lobular Carcinoma: Alma's Patient Story

Patient Info: Alma, Female | Stage II

Alma had Stage II invasive lobular carcinoma treated with lumpectomy, chemotherapy, radiation, and planned 10 years of tamoxifen, then found a local recurrence 4.5 years after diagnosis.

Lobular Breast Cancer Alliance
OutcomeSetback / Progression
Tanya, who was diagnosed with Stage II Invasive Lobular CarcinomaBreast Cancer

Stage II HR-Positive Invasive Lobular Carcinoma: Tanya's Patient Story

Patient Info: Tanya, Female, 40s | Stage II

Biomarkers: Genetic testing negative; Oncotype DX score 27; MammaPrint low risk; ER-positive

Tanya had Stage II ER-positive breast cancer with a large lobular tumor found on MRI, underwent bilateral mastectomy with immediate reconstruction, completed 4 rounds of chemotherapy, and started tamoxifen.

Lobular Breast Cancer Alliance
OutcomeCare Ongoing
Nikoo, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Stage IV HR-Positive Invasive Lobular Carcinoma: Nikoo's Patient Story

Patient Info: Nikoo, Female | Stage IV

Biomarkers: ER-positive; PR-positive; HER2-negative

Metastatic Site: Peritoneum | Ascites | Possible bone

Nikoo’s early lobular breast cancer treated in 2003 with lumpectomy, radiation, and 5 years of tamoxifen recurred 19 years later as ER-positive, PR-positive, HER2-negative metastatic lobular breast cancer involving the peritoneum, ascites, and possible bone.

Lobular Breast Cancer Alliance
OutcomeSetback / Progression
Lisa, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Stage IV Invasive Lobular Carcinoma: Lisa's Patient Story

Patient Info: Lisa, Female | Stage IV

Metastatic Site: Bone

Lisa’s 2017 lobular breast cancer was found to be Stage II after bilateral mastectomy and reconstruction; despite tamoxifen, back pain 3 years later led to PET-confirmed metastatic ILC in the bones.

Lobular Breast Cancer Alliance
OutcomeSetback / Progression
Kevin, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Kevin's Patient Story

Patient Info: Kevin Jarvis, Male | Stage I

Biomarkers: Genetic testing inconclusive; receptor status not reported

Early male breast cancer treated with mastectomy, sentinel node biopsy, EC chemotherapy, paclitaxel/Taxol, and ongoing daily tamoxifen; latest source text describes good spirits and continued discussion of risk-reducing surgery, but does not explicitly state NED.

Cancer Council Australia
OutcomeCare Ongoing
Roger, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Roger's Patient Story

Patient Info: Roger, Male

Managing male breast cancer care on a lower dose of tamoxifen after severe side effects, while using support services and advocating for male breast cancer awareness.

Macmillan Cancer Support
OutcomeCare Ongoing
Rachel, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II BRCA2 Breast Cancer: Rachel's Patient Story

Patient Info: Rachel Zitofsky, Female, Under 40 | Stage II

Biomarkers: BRCA2 mutation

Rachel was doing well 4.5 years after Stage II breast cancer diagnosis and continued tamoxifen; her BRCA2 result also led her sister to expanded testing and preventive care.

Memorial Sloan Kettering
OutcomeCare Ongoing
Amy, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Amy's Survivor Story

Patient Info: Amy Mannarino, Female, 50s | Stage IV

Metastatic Site: Brain

After brain metastasis surgery and 3 radiation sessions, Amy was doing well with no evidence of disease; the source specifically distinguishes NED from being cured or cancer-free in the setting of metastatic disease.

Memorial Sloan Kettering
OutcomeCancer-Free / NED
Jim, who was diagnosed with Breast CancerBreast Cancer

HER2-Positive Breast Cancer: Jim's Patient Story

Patient Info: Jim Keegan, Male, 70+

Biomarkers: HER2-positive; BRCA1/BRCA2 negative

Jim completed surgery, chemotherapy and 1 year of Herceptin for early-stage HER2-positive male breast cancer, then continued tamoxifen and yearly MSK surveillance while advocating for male breast cancer awareness.

Memorial Sloan Kettering
OutcomeCare Ongoing
Michelle, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Michelle's Survivor Story

Patient Info: Michelle Kang, Female, Under 40 | Stage I

Biomarkers: Hormone-positive breast cancer; no suspicious inherited genetic mutation reported

Michelle was 6 years cancer-free after Stage 1B hormone-positive breast cancer while continuing hormone therapy, Zometa, Signatera blood testing, reconstruction follow-up, and survivorship monitoring.

City of Hope
OutcomeCancer-Free / NED
A patient, who was diagnosed with Invasive Lobular CarcinomaBreast Cancer

Radiation-related morphea years after breast cancer treatment

Patient Info: Anonymized, Female, 50s

Biomarkers: ER-positive; PR-positive; HER2-negative

At follow-up in March 2026, more than 10 years after her breast cancer diagnosis, she remained free of oncologic recurrence and had completed 10 years of tamoxifen.

PubMed Central
OutcomeCancer-Free / NED